This article is more than 5 years old. Information may no longer be current.

Clearside announces pricing of initial public offering

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Clearside Biomedical announced that its initial public offering of 7.2 million shares of common stock will be priced at $7 per share, according to a press release.

Shares were expected to begin trading on the Nasdaq Global Market on June 2 under the symbol “CLSD.” The offering is expected to close on June 7, subject to customary closing conditions, the release said.

The company has also granted underwriters 30 days to purchase up to an additional 1.08 million shares of common stock at the public offering price.